SNMMI Highlighting PET/MRI and Therapeutics in Two Unique Events
Therapeutics and PET/MRI are both areas of intense focus and innovation in nuclear medicine. The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is actively
Therapeutics and PET/MRI are both areas of intense focus and innovation in nuclear medicine. The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is actively
NETSPOT (68Ga-Dotatate) is a radioactive diagnostic agent used for PET imaging that is gaining ground among practices. FDA-approved in 2016, NETSPOT is used in imaging
PET/CT is a vital diagnostic imaging tool and is especially effective in revealing conditions such as cancer and brain disorders. When it comes to Medicare
The two most common approaches after identifying a solitary pulmonary nodule are the wait-and-see approach, or to move straight to a biopsy. While medically sound,
The landscape of PET/CT imaging is rapidly changing. Traditionally, physicians have used a sugar based radiopharmaceutical, 18Fluorodeoxyglucose or 18FDG, to perform the majority of PET/CT imaging.